Generics

Alembic rolls out generic Viibryd

Generic Viibryd is indicated for the treatment of major depressive disorder in adults.
Amgen’s Rituxan biosimilar gets FDA OK for new indication

Amgen’s Riabni is now also approved for adults with moderate to severe rheumatoid arthritis.
Ascend Labs receives 2 DIANA awards

Ascend was recognized as a First Merit finalist in the Best Overall Generic Pharmaceutical Product Manufacturer with more than $100 million in sales category.
Camber intros generic Trileptal

The medication is indicated as monotherapy or adjunctive therapy in the treatment of partial-onset seizures in adults.
Alembic intros 2 generics

Alembic's latest generic offerings are entacapone tablets, nystatin and triamcinolone acetonide ointment.
New Jersey pharmacist opens nonprofit pharmacy for the uninsured

Ritesh Shah Charitable Pharmacy in Red Bank, N.J., offers medications, immunizations, health education and counseling.
Camber launches generic Pepcid

The medication is indicated for the treatment of active duodenal ulcer, active gastric ulcer and symptomatic nonerosive gastroesophageal reflux disease.
Amneal debuts 2 generics

The company is offering Lyvispah, a baclofen oral granules specialty product, and bexarotene gel, 1%.

Senate committee moves FDA User Fee bill with 5 NACDS-backed provisions